Exponential Growth Forecasted for Global Gene Therapy Market: Market Size, Key Players, and Leading Trends Detailed

Riding on the Wave of Exponential Growth: Global Gene Therapy Market to Reach $31.48 Billion by 2029 with a CAGR of 17.8%.

What Is The Projected Market Size Of The Global Gene Therapy Market And Its Growth Rate?
The global gene therapy market has been witnessing explosive growth in recent years:
- The market surged from $12.52 billion in 2024 to an anticipated $16.36 billion in 2025, marking a compound annual growth rate (CAGR) of 30.7%.
- This growth can largely be attributed to rising pharmaceutical R&D expenditure, an increase in public-private partnerships, government investments, and an upswing in cases of spinal muscular atrophy.
- Looking ahead, the market size is forecasted to continue its robust growth, reaching $31.48 billion in 2029 with a CAGR of 17.8%.
- This future growth will be driven by an escalating number of cancer cases, a burgeoning aging population, increasing research and development expenditure in the pharmaceutical sector, and an intensified focus on gene therapy.

What Is Driving The Growth In The Gene Therapy Market?
The alarming rise in incidences of cancer and other target diseases is driving the growth of the global gene therapy market. The surge in cancer cases worldwide is expected to significantly bolster the market during the coming years. For example, the American Cancer Society reported in January 2022, that there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US alone representing roughly 1,670 fatalities every day. The four most common types of cancer worldwide-lung, prostate, bowel, and female breast cancer-account for 43 percent of all new cases. Consequently, the surge in cancer incidence is likely to stimulate demand for gene therapy over the forthcoming years. Notably, gene therapy, which introduces new genes into a cancerous cell or its surrounding tissue to cause cell death or impede the growth of cancer, is recognized as one of the most effective treatments in oncology.

For a more in-depth understanding, [Request A Free Sample Copy](https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp)

Who Are the Key Players Driving Gene Therapy Market Growth?
Several major companies are instrumental to the growth of the gene therapy market, including:
- UniQure NV
- REGENXBIO Inc.
- Bristol-Myers Squibb
- BioMarin Pharmaceuticals Inc.
- Jazz Pharmaceuticals Inc.
- Biocon
- Cipla
- EdiGene Inc
- Takeda Pharmaceutical
- Daiichi Sankyo Company
- Mitsubishi Tanabe Pharma
- Merck
- GE Healthcare
- Lonza
- Pfizer
- Cellular Biomedicine Group
- GenScript
- Albumedix Ltd
- Catalent
- Freeline Therapeutics
- DiNAQOR AG
- Vivet Therapeutics
- Allergan
- Amgen
- Biocad
- Celgene Corporation
- Johnson & Johnson
- Eli Lilly and Company
- AstraZeneca
- Bayer AG
- Juno Therapeutics
- Allogene Therapeutics
- Bluebird Bio
- Regen BioPharma
- Bellicum
- Biotchpharma
- BrainStorm Cell Therapeutics
- Pluristem
- Sanofi

What Are The Key Trends In The Gene Therapy Market?
Prominent trends in the forecast period include:
- Enhancing business operations through securing regulatory approvals
- Strengthening business activities through strategic collaborations and partnerships
- Expanding business capabilities through strategic acquisitions
- Strengthening operational capabilities through business expansions

What Are The Segments Of The Global Gene Therapy Market?
The global gene therapy market is segmented by:
- Gene Therapy Type: Germline Therapy, Somatic Cell Therapy
- Vector: Viral Vector, Non-Viral Vector
- Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders
- End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Which Region Leads The Gene Therapy Market?
North America led the gene therapy market in 2024, showing the highest market value. The other regions covered in the market report include Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.

Get the full report swiftly delivered by [Pre-booking](https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report)

What Is Covered In The Gene Therapy Market Global Market Report?
- Market Size Analysis: Analyze the Gene Therapy Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Gene Therapy Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Gene Therapy Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Gene Therapy Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

For report tailoring to your specific needs, [Request Customization](https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp)

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.